MSF testifies in Congress on India's right to keep lifesaving medicines affordable.

More >

In this blog post from BMJ Group Blogs, lawyer and India manager of MSF's Access Campaign Leena Menghaney discusses the two legal battles that are taking center stage in the struggle over India's medicines patent law.

More >

MSF's appeal to Novartis to drop its case against India continues as the pharmaceutical company's day in court draws near.

More >

Kala azar, a disease transmitted by certain types of sand flies, is endemic in much of Bihar. It causes enlargement of the spleen and, if left untreated, is fatal for virtually all patients.

More >

In 2005, India put in place a patent law—fortunately it’s a law that supports public health objectives, so the result has been that India's generic manufacturers have had some space to continue producing affordable and effective medicines.

More >

Despite the continuing tense situation, MSF counselors have restarted visiting patients in the hospitals in the capital, Srinagar, and are offering on-the-spot psychological assistance to victims of violence and their families.

More >

Violence and curfews have forced MSF to suspend its mental health care programs in the Kashmir Valley.

More >

Following a sharp increase in malaria cases in Mumbai, MSF has launched a malaria intervention to help local health authorities fight the disease.

More >

Closed-door negotiations between India and the EU are entering a crucial phase; at stake is access to affordable medicines for millions.

More >

An Indian court has stopped the international pharmaceutical company Bayer?s latest attempt to introduce new measures to prevent generic competition in India.

More >

Pages